特发性血小板减少性紫癜(简称 ITP)是一种自身免疫性疾病,过去对其诊断系根据临床表现或其他间接检查抗体方法。近年来已能直接测定每个血小板上抗体的浓度,并可借以预测疗效与预后.对该症的治疗现已有不少新的方法,兹将其诊断和治疗等方面的进展简述如下:一、ITP 的诊断自从 Dixon 等对 ITP 的诊断采取直接测定血小板表面抗血小板抗体浓度以来,过去所用的凝集试验、补体结合与抗人球蛋白消耗试验、血清素与血小板因子3的释放以及血小板抗体刺激淋巴细 Idiopathic thrombocytopenic purpura (referred to as ITP) is an autoimmune disease, the past diagnosis of its Department based on clinical manifestations or other indirect antibody testing methods. In recent years, the concentration of antibody on each platelet has been directly measured, and the efficacy and prognosis can be predicted. There are many new methods for the treatment of this disease, and the progress of its diagnosis and treatment are briefly described as follows: First, the diagnosis of ITP Since Dixon and other diagnostic tests for ITP to take a direct determination of platelet surface anti-platelet antibody concentration since the agglutination test used in the past, complement fixation and anti-human globulin consumption test, the release of serotonin and platelet factor 3 and platelet antibodies Stimulate lymph nodes